While blood and tissue eosinophilia is a hallmark of most invasive helminth infections, the full role of the eosinophil in the inflammatory reaction or the protective responses to parasites is not understood. Evidence continues to accumulate showing that the eosinophil, on an evolutionary basis, has been selected for its capacity to be cytotoxic for helminth parasites and is thereby a major defense in the host's protective immune response against these organisms, although eosinophil-associated pathology is found frequently in both atopy and helminth infections. Whatever their role, however, an understanding of how eosinophil responses are regulated, recruited to sites on inflammation and activated in filarial infections and other pathological states is one specific aim of this project. A remarkable and common feature of human helminth infections is the predominant elevations of IgE and IgG4 antibodies directed to exogenous antigens. While the preferential elevation of IgE is felt to be responsible for mediating immediate hypersensitivity reactions through binding to high affinity FcER on basophils and mast cells, the parallel increase of IgG4 with that of IgE has been postulated to act as a control element for the IgE-mediated immediate hypersensitivity reaction by blocking the access of the soluble allergens to the IgE coated mast cells. Based on this observation of a preferential and parallel response by IgE and IgG4 isotypes, it might be predicted that regulation of these two isotypes may be similar and distinct from the other IgG subclasses. The purpose of this part of the project, thus, is to understand the regulation of these two isotypes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000805-01
Application #
6160796
Study Section
Special Emphasis Panel (LPD)
Project Start
Project End
Budget Start
Budget End
Support Year
1
Fiscal Year
1997
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Klion, Amy (2009) Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu Rev Med 60:293-306
Klion, Amy D (2009) How I treat hypereosinophilic syndromes. Blood 114:3736-41
Cooper, Philip J; Mitre, Edward; Moncayo, Ana Lucia et al. (2008) Ascaris lumbricoides-induced interleukin-10 is not associated with atopy in schoolchildren in a rural area of the tropics. J Infect Dis 197:1333-40
Kim, Yae-Jean; Dale, Janet K; Noel, Pierre et al. (2007) Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome. Am J Hematol 82:615-24
Klion, Amy D; Robyn, Jamie; Maric, Irina et al. (2007) Relapse following discontinuation of imatinib mesylate therapy for FIP1L1/PDGFRA-positive chronic eosinophilic leukemia: implications for optimal dosing. Blood 110:3552-6
Maric, Irina; Robyn, Jamie; Metcalfe, Dean D et al. (2007) KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1/PDGFRA-associated chronic eosinophilic leukemia are distinct entities. J Allergy Clin Immunol 120:680-7
Nutman, Thomas B (2007) Evaluation and differential diagnosis of marked, persistent eosinophilia. Immunol Allergy Clin North Am 27:529-49
Robyn, Jamie; Lemery, Steven; McCoy, J Philip et al. (2006) Multilineage involvement of the fusion gene in patients with FIP1L1/PDGFRA-positive hypereosinophilic syndrome. Br J Haematol 132:286-92
Mitre, Edward; Nutman, Thomas B (2006) IgE memory: persistence of antigen-specific IgE responses years after treatment of human filarial infections. J Allergy Clin Immunol 117:939-45
Kim, Yae-Jean; Nutman, Thomas B (2006) Eosinophilia: causes and pathobiology in persons with prior exposures in tropical areas with an emphasis on parasitic infections. Curr Infect Dis Rep 8:43-50

Showing the most recent 10 out of 41 publications